Hold-rated reports

932 tickers rated Hold
Ranks this page's recent reports by score.
Molson Coors Beverage Company
TAP·Consumer Staples
B ★★★Hold
Current$40.12
Target$47.90
Return+19.4%
Oct 31, 2026

Molson Coors offers inexpensive cash generation, established beer brands, and attractive shareholder returns, but declining mainstream beer demand and margin pressure threaten its long-term earnings durability.

Score
74
Flowserve Corporation
FLS·Industrials
B ★★★Hold
Current$79.01
Target$83.70
Return+5.9%
Oct 31, 2026

Flowserve benefits from a durable industrial installed base, record backlog, and nuclear-power expansion opportunities, but elevated valuation and weak organic sales and cash conversion limit near-term upside.

Score
65
SPX Technologies, Inc.
SPXC·Industrials
B ★★★Hold
Current$159.95
Target$195.40
Return+22.2%
Oct 31, 2026

SPX Technologies offers structural growth through data-center cooling and specialized HVAC equipment, but acquisition-related leverage, margin compression, and demanding long-term cash-flow assumptions constrain the investment case.

Score
70
Huntington Ingalls Industries, Inc.
HII·Industrials
B ★★★Hold
Current$316.88
Target$357.00
Return+12.7%
Oct 31, 2026

Huntington Ingalls benefits from an exceptionally durable U.S. naval shipbuilding franchise and substantial submarine demand, but working-capital volatility and shipyard execution risks limit the margin of safety at its current valuation.

Score
72
BioMarin Pharmaceutical Inc.
BMRN·Healthcare
B ★★★Hold
Current$58.51
Target$77.00
Return+31.6%
Oct 31, 2026

BioMarin combines durable rare-disease drug franchises, expanding VOXZOGO adoption, and acquisition-driven growth with appealing normalized valuation, but integration debt, margin pressure, and clinical competition limit near-term conviction.

Score
71
Wayfair Inc.
W·Consumer Discretionary
B ★★★Hold
Current$115.91
Target$120.66
Return+4.1%
Oct 31, 2026

Wayfair's improving customer growth, operating leverage, and cash generation support an earnings-recovery thesis, but cyclical furniture demand, financial leverage, and demanding valuation limit its immediate investment appeal.

Score
66
Owens Corning
OC·Industrials
B ★★★Hold
Current$121.15
Target$130.00
Return+7.3%
Oct 31, 2026

Owens Corning's high-margin roofing franchise, cash generation, and restructuring benefits offer attractive recovery potential, but weak housing demand, Doors execution risks, and cyclical earnings uncertainty limit near-term conviction.

Score
69
PPL Corporation
PPL·Utilities
B ★★★Hold
Current$35.65
Target$38.16
Return+7.0%
Oct 31, 2026

PPL offers durable regulated utility cash flows, dividend income, and earnings growth supported by grid investment and electricity demand, but elevated capital spending and leverage constrain its valuation upside.

Score
70
Oscar Health, Inc.
OSCR·Healthcare
B ★★★Hold
Current$30.37
Target$35.52
Return+17.0%
Oct 31, 2026

Oscar Health combines rapid ACA membership growth with improving underwriting profitability, but shareholder dilution, medical-cost volatility, and dependence on healthcare policy constrain the long-term investment case.

Score
66
Atlassian Corporation
TEAM·Technology
B ★★★Hold
Current$191.72
Target$195.84
Return+2.1%
Oct 31, 2026

Atlassian combines a durable enterprise software ecosystem with strong cloud growth and expanding AI opportunities, but demanding valuation, stock compensation costs, and uncertain future margin conversion limit near-term upside.

Score
70
EOG Resources, Inc.
EOG·Energy
B ★★★Hold
Current$165.54
Target$175.00
Return+5.7%
Oct 31, 2026

EOG combines efficient shale production, strong free cash flow, and disciplined shareholder returns with an expanded Utica resource base, but its elevated historical valuation and sensitivity to commodity prices constrain near-term upside.

Score
70
Allison Transmission Holdings, Inc.
ALSN·Consumer Discretionary
B ★★★Hold
Current$108.05
Target$123.86
Return+14.6%
Oct 31, 2026

Allison's profitable transmission franchise and off-highway integration opportunities support long-term earnings recovery, but acquisition leverage, cyclical demand and uncertain margin improvement constrain the near-term investment case.

Score
71